Mato, A., Roeker, L., Eyre, T., Ujjani, C., Lamanna, N., Hill, B., … Brander, D. (2020). Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL). In LEUKEMIA & LYMPHOMA (Vol. 61, pp. 193–195).

Mato, Anthony, Lindsey Roeker, Toby Eyre, Chaitra Ujjani, Nicole Lamanna, Brian Hill, Paul Barr, et al. “Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL).” In LEUKEMIA & LYMPHOMA, 61:193–95, 2020.

Mato A, Roeker L, Eyre T, Ujjani C, Lamanna N, Hill B, et al. Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL). In: LEUKEMIA & LYMPHOMA. 2020. p. 193–5.

Mato, Anthony, et al. “Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL).” LEUKEMIA & LYMPHOMA, vol. 61, 2020, pp. 193–95.

Mato A, Roeker L, Eyre T, Ujjani C, Lamanna N, Hill B, Barr P, Lansigan E, Cheson BD, Yazdy M, Allan J, Rhodes J, Kennard K, Schuster S, Nabhan C, Skarbnik A, Goy A, Dorsey C, Goodfriend J, Coombs C, Tuncer HH, Pagel J, Jacobs R, Kirkwood A, Winter A, Schuh A, Bailey N, Sitlinger A, Shadman M, Fox C, Brander D. Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL). LEUKEMIA & LYMPHOMA. 2020. p. 193–195.